Denali’s DNL343 missed efficacy goals in the HEALEY ALS trial but was well-tolerated. Analysts await detailed biomarker data and subgroup analyses in 2025. Latest Ratings for DNLI Date Firm Action From To Jan 2022 Morgan Stanley Maintains Overweight Sep 2021 Oppenheimer Initiates Coverage On Outperform Aug 2021 Morgan Stanley Maintains Overweight View More Analyst Ratings…
Chairman of the U.S. Commodity Futures Trading Commission Rostin Behnam resigns, leaving the agency stronger and more focused on regulating cryptocurrency. read more
Coca-Cola Co has attractive and sustainable growth drivers, including exposure to emerging markets, according to Piper Sandler analyst Michael Lavery. With a price target of $74, Coca-Cola’s strong marketing and franchised bottling system contribute to its long-term growth. Latest Ratings for KO Date Firm Action From To Feb 2022 Deutsche Bank Maintains Hold Feb 2022…
LOGI shares up premarket as Streamlabs partners with NVIDIA and Inworld AI to launch AI-powered streaming assistant, enhancing live streaming experience. read more
Two bodies were discovered inside the wheel well of a JetBlue Airways Corp (NASDAQ:JBLU) plane after landing in Florida on Monday night. Here’s what you need to know. read more
